Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wetzel

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|July 3, 1998
Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostateW C Wong, G Chiu, J M Wetzel, et al.
Journal of Medicinal Chemistry|December 19, 1998
Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasiaD Nagarathnam, J M Wetzel, S W Miao, et al.
Journal of Medicinal Chemistry|August 3, 2007
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hitsChien-An Chen, Yu Jiang, Kai Lu, et al.
Critical Care Nursing Clinics of North America|November 29, 2011
A journey through heart valve surgeryMallory Piaschyk, Alaina M Cyr, Amy M Wetzel, et al.
Plos One|April 20, 2026
Longitudinal brain health and neurological correlates of sexual strangulation in young adults: Study protocol for a prospective cohort studyKeisuke Kawata, Claire V Buddenbaum, Megan E Huibregtse, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine seriesW C Wong, W Sun, B Lagu, et al.
Journal of Medicinal Chemistry|August 24, 2000
De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailabilityB Lagu, D Tian, Y Jeon, et al.
Maternal Health, Neonatology and Perinatology|December 23, 2017
NEC-zero recommendations from scoping review of evidence to prevent and foster timely recognition of necrotizing enterocolitisSheila M Gephart, Corrine Hanson, Christine M Wetzel, et al.
The Journal of Biological Chemistry|October 12, 2000
Identification and characterization of two G protein-coupled receptors for neuropeptide FFJ A Bonini, K A Jones, N Adham, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinonesD Nagarathnam, S W Miao, B Lagu, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|July 3, 1998
Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostateW C Wong, G Chiu, J M Wetzel, et al.
Journal of Medicinal Chemistry|December 19, 1998
Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasiaD Nagarathnam, J M Wetzel, S W Miao, et al.
Journal of Medicinal Chemistry|August 3, 2007
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hitsChien-An Chen, Yu Jiang, Kai Lu, et al.
Critical Care Nursing Clinics of North America|November 29, 2011
A journey through heart valve surgeryMallory Piaschyk, Alaina M Cyr, Amy M Wetzel, et al.
Plos One|April 20, 2026
Longitudinal brain health and neurological correlates of sexual strangulation in young adults: Study protocol for a prospective cohort studyKeisuke Kawata, Claire V Buddenbaum, Megan E Huibregtse, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine seriesW C Wong, W Sun, B Lagu, et al.
Journal of Medicinal Chemistry|August 24, 2000
De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailabilityB Lagu, D Tian, Y Jeon, et al.
Maternal Health, Neonatology and Perinatology|December 23, 2017
NEC-zero recommendations from scoping review of evidence to prevent and foster timely recognition of necrotizing enterocolitisSheila M Gephart, Corrine Hanson, Christine M Wetzel, et al.
The Journal of Biological Chemistry|October 12, 2000
Identification and characterization of two G protein-coupled receptors for neuropeptide FFJ A Bonini, K A Jones, N Adham, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinonesD Nagarathnam, S W Miao, B Lagu, et al.
Pageof 13